CoronaryAtlas logo
CoronaryAtlas
Acyl-alkyl-phosphatidylcholine C36:3
Pathway / Lipid retention & oxidation

Acyl-alkyl-phosphatidylcholine C36:3

lipid

Acyl-alkyl (plasmalogen) phosphatidylcholine composition independently predicts MI risk via altered lipoprotein biology.

Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationalePlasmalogen species predicts MI; reflects lipid remodeling in atherogenic lipoproteins.
Druggability
Not assessed (no mapped human gene target).

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma (EDTA to limit oxidation)
Collection tube
K2/K3-EDTA (lavender-top) · Serum separator (gold/red-top, SST)
Method / principle
LC-MS/MS lipidomics (targeted or shotgun)
Reagent / substrate
Deuterated lipid-class internal standards; MS/MS transitions
Platform
LC-MS/MS
Turnaround · availability
Research · Research-only

Literature evidence(1)